Palantir Technologies Inc. - Class A Common Stock (PLTR)
172.56
-0.75 (-0.43%)
NASDAQ· Last Trade: Sep 16th, 2:41 AM EDT
Burry made a fortune by shorting the mortgage bond market ahead of the financial crisis.
Via The Motley Fool · September 16, 2026
The rising effectiveness of artificial intelligence is creating an increasing demand for enterprise implementation.
Via The Motley Fool · September 15, 2026
Palantir, Marvell, and Snowflake could be good buys on a pullback.
Via The Motley Fool · September 15, 2026
When the Fed last raised interest rates in July 2023, these stocks all soared more than 65% in the following 12 months.
Via The Motley Fool · September 15, 2026
Palantir's growth story is changing fast. See why commercial AI could reshape the company's earnings power, and why its premium valuation makes the next phase so important.
Via The Motley Fool · September 15, 2026
Palantir revealed what CEO Alex Karp believes could be the company's secret sauce for long-term success.
Via The Motley Fool · September 15, 2026
Certain Wall Street analysts expect major losses for shareholders of Palantir and SpaceX.
Via The Motley Fool · September 15, 2026
Over the past six months, Blackstone has been a great trade, beating the S&P 500 by 5.7%. Its stock price has climbed to $128.45, representing a healthy 19.9...
Via StockStory · September 15, 2026
Kimball Solutions has been treading water for the past six months, recording a small return of 2.9% while holding steady at $23.94. The stock also fell short...
Via StockStory · September 15, 2026
Kirby trades at $137.53 per share and has stayed right on track with the overall market, gaining 10.6% over the last six months. At the same time, the S&P 50...
Via StockStory · September 15, 2026
Rubrik stock, Palantir Technologies, CrowdStrike, Corpay and Dorchester Minerals are among the 21 stocks joining IBD watchlists Monday.
Via Investor's Business Daily · September 14, 2026
The stock is trading near its 52-week low, but it may have significant upside in the long run.
Via The Motley Fool · September 14, 2026
What Happened? Shares of electronics manufacturing services provider Jabil (NYSE:JBL) fell 5.1% in the afternoon session after Goldman Sachs lowered its pric...
Via StockStory · September 14, 2026
Is it a buy on the dip or a value trap?
Via The Motley Fool · September 14, 2026
These ETFs each offer a distinct strategy for creating long-term wealth.
Via The Motley Fool · September 14, 2026
Arcade company Dave & Buster’s (NASDAQ:PLAY) will be announcing earnings results this Monday afternoon. Here’s what to expect. Dave & Buster's missed analyst...
Via StockStory · September 12, 2026
The AI data analytics giant could run up against a wall in the near future.
Via The Motley Fool · September 12, 2026
Palantir, Salesforce, and Meta are three agentic AI stocks to own today.
Via The Motley Fool · September 12, 2026
Stocks fell this week on oil prices and Fed rate-hike expectations, though Oracle's earnings underscored AI infrastructure strength. MarketBeat analysts recap top stories on earnings, defense, AI, and other stock opportunities.
Via MarketBeat · September 12, 2026
SpaceX stock is currently sitting near its opening-day first trading price of $150.
Via The Motley Fool · September 12, 2026
Burry continues to short growth stocks, but it hasn't always been a winning formula.
Via The Motley Fool · September 12, 2026
Amazon is a fantastic artificial intelligence investment.
Via The Motley Fool · September 11, 2026
Inovio Pharmaceuticals (NASDAQ:INO) said its biologics license application for INO-3107, an investigational DNA medicine for recurrent respiratory papillomatosis, or RRP, remains under U.S. Food and Drug Administration review, with a target action date of Oct. 30.
President and CEO Jacqueline Shea
Via MarketBeat · September 11, 2026
The CEO tied the whole business to its hottest segment's pace for the next 18 months. Here's what that implies in dollars.
Via The Motley Fool · September 11, 2026